Herein, SBE application resulted in the downregulation of cyclin D, E, and CDK2/4/6, which hindered the progression of HCC cells from the G1 phase to the S phase, as was observed in the flow cytometry analysis. The gene discussed is CDK2; the disease is hepatocellular carcinoma.